Current models of retroviral entry hypothesize that interactions between th
e host cell receptor(s) and viral envelope protein induce structural change
s in the envelope protein that convert it to an active conformation, allowi
ng it to mediate fusion with the membrane. Recent evidence supporting this
hypothesis is the demonstration that Tva, the receptor for subgroup A avian
sarcoma and leukosis virus (ASLV-A), induces conformational changes in the
viral envelope protein. These changes include conversion of the envelope p
rotein to an active, membrane-binding state likely representing a fusogenic
conformation. To determine whether binding of the soluble Tva (sTva) recep
tor was sufficient to activate fully the fusogenic potential of the ASLV-A
envelope protein, we have evaluated the ability of ASLV-A to infect recepto
r-deficient cell Lines in the presence of sTva. Soluble receptor efficientl
y mediated infection of cells devoid of endogenous Tva in a dose-dependent
manner, and this infection was dependent absolutely on the addition of sTva
. The infectivity of the virus was enhanced dramatically in the presence of
the polycationic polymer Polybrene or when centrifugal forces were applied
during inoculation, resulting in viral titers comparable to those achieved
on cells expressing endogenous receptor. sTva functioned to mediate infect
ion at low concentrations, approaching the estimated binding constant of th
e receptor and viral envelope protein. These results demonstrate that recep
tor binding can activate the ASLV-A envelope protein and convert it to a fu
sogenic conformation competent to mediate the fusion of the viral and cellu
lar membranes.